They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...
"This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and ...
Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...
Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) seized the world's largest cache of unlicensed ...
The EMA is working with social media content creators to try to encourage "safe and responsible" use of weight-loss drugs.
Zacks Investment Research on MSN
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings
While Eli Lilly LLY is a market leader in the GLP-1 segment, thanks to its tirzepatide medicines Mounjaro and Zepbound (for ...
Eli Lilly jumps to top 10% in quality rankings, showing strong fundamentals even as Trump pushes for weight loss drug price ...
Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, ...
Shares of Eli Lilly and Novo Nordisk fell Friday, Oct. 17 after Pres. Donald Trump said the price of the weight-loss drug Ozempic could soon drop to $150 a month.
Prescribing rates remained stable from June to September, according to an analysis of EHR data from researchers at Truveta — a platform that includes ...
Prescription-drug costs were the top-cited factor for rising premiums, according to large businesses surveyed by the think tank. Two-thirds of large businesses said GLP-1s for weight loss had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results